Germany sets three-year schedule for adopting DRG (diagnosis related group) system
This article was originally published in Clinica
Executive Summary
Having taken the decision to adopt Australia's refined diagnosis related group (AR-DRG) system of hospital reimbursement, German healthcare officials now have to start the hard work of adapting the system to their own conditions. Kevin Sullivan looks at the implications of the decision for the country's healthcare provision and for suppliers of medtech.
You may also be interested in...
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.